Opioid Free Anesthesia in Maxillofacial Surgery

August 28, 2021 updated by: Ismael Guibla, Université NAZI BONI

Efficiency of Opioid-free Anesthesia (OFA) in Maxillofacial Surgery

Opioid free anesthesia is a promising practice in anesthesia. Studies already carried out have compared OFA to an opioid or "opioid anesthesia" (OA) protocol without the use of antihyperalgesic in the OA protocol. Most of the studies currently available have been carried out in Europe, America and a few in Asia under conditions other than those available in precarious situations.That's why we decide to conduct a study to evaluate the effectiveness of an OFA protocol in maxillofacial surgery in Burkina Faso.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The patients were recruited at the University Hospital of Souro Sanou in Bobo Dioulasso

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Houet
      • Bobo-Dioulasso, Houet, Burkina Faso
        • Guibla

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients aged between 15 and 65 years, admitted to the central operating room of the hospital for maxillofacial surgery.

Exclusion Criteria:

  • Known or suspected coronary artery disease on preoperative consultation;
  • Unstable arterial hypertension
  • Insulin-dependent diabetes
  • Second degree atrioventricular block
  • Neuro-vegetative dysautonomia;
  • known allergy or intolerance to a drug of the protocols

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group 1
Intervention consists at induction : direct intravenous lidocaine 1.5 mg/kg; clonidine 2 μg/kg in 250 ml of isotonic saline, started as soon as the venous route is taken and over a period of approximately 15 minutes; magnesium sulfate 50 mg/kg in the same isotonic saline as clonidine.
Maintenance of anesthesia was done with halothane. The incision was allowed at 1.2 MAC of halothane. This halogen was administered according to the hemodynamic parameters and the habits of the anesthesia team. Before waking up, all the patients benefited from preventive analgesia with 1 g paracetamol combined with 20 mg nefopam by slow intravenous injection over approximately 15 minutes.
No Intervention: group 2
In classic induction: fentanyl at a dose of 2 µg/kg. Following induction in all patients consisted of the administration of propofol 2-3 mg/kg in titration, rocuronium 0.6 mg/kg, ketamine 0.5 mg/kg, methylprednisolone 120 mg.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Highest numerical pain score
Time Frame: First two hours postoperatively
The main highest numerical pain score postoperatively
First two hours postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure
Time Frame: six minutes after incision
Changes in blood pressure
six minutes after incision
Ephedrine
Time Frame: During anesthesia
Intraoperative consumption of ephedrine
During anesthesia
Wake up
Time Frame: Time between the end of surgery and extubation
wake up time
Time between the end of surgery and extubation
Nausea-Vomiting
Time Frame: During 24 after surgery
The proportion of nausea-vomiting after surgery
During 24 after surgery
Highest numerical pain score 24 hours
Time Frame: The first 24 hours postoperatively
The mean of the highest EN score during the first 24 hours postoperatively
The first 24 hours postoperatively
Non-surgical complications
Time Frame: During 24 hours after surgery
The proportion of non-surgical complications within 24 hours of anesthesia
During 24 hours after surgery
Heart rate
Time Frame: six minutes after incision
Changes in heart rate
six minutes after incision

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ismael Guibla, Doctor, University Hospital Souro Sanou, Burkina Faso
  • Study Chair: Charles Ilboudo, Doctor, University Hospital Souro Sanou, Burkina Faso
  • Study Chair: Bertille Ki, Professor, Univesity of Joseph KI-ZERBO, Health sciences institute
  • Study Chair: Jean Paul Lechat, Doctor, Hospital of Charleroi (GHdC), Belgium
  • Study Chair: Cheick Bougouma, Doctor, Univesity of Joseph KI-ZERBO, Health sciences institute
  • Study Director: Alain Traore, Professor, University of Nazi Boni, Health sciences institute
  • Study Director: Flavien Kabore, Professor, Univesity of Joseph KI-ZERBO, Health sciences institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2019

Primary Completion (Actual)

June 15, 2020

Study Completion (Actual)

October 5, 2020

Study Registration Dates

First Submitted

August 7, 2021

First Submitted That Met QC Criteria

August 28, 2021

First Posted (Actual)

September 2, 2021

Study Record Updates

Last Update Posted (Actual)

September 2, 2021

Last Update Submitted That Met QC Criteria

August 28, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Use number and date to find participant folder. Participant data are confidential.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Maxillofacial Surgery

Clinical Trials on opioid free anesthesia

3
Subscribe